Lino Biotech
Lino Biotech – Pioneering label-free interaction analysis with focal Molography. Lino Biotech AG is a Swiss life science company, fully owned by Miltenyi Biotec, and the exclusive developer of focal Molography, a disruptive optical technology for label-free biomolecular interaction analysis. Based in Zurich, we empower drug discovery and biopharma research by enabling scientists to study interactions in real biological environments, not just in artificial buffers. With our MACS® Matchmaker platform, we bring unique advantages to the table: ultra-low sample consumption, drift-free kinetics, and multiplexed analysis of up to 64 interactions in parallel. From DEL hit validation to cell-based assays, our solutions help innovators save time, reduce costs, and generate more physiologically relevant data. As part of the Miltenyi Biotec family, we combine Swiss innovation with global reach—driving forward a vision to make drug discovery smarter, faster, and more reliable.